261 related articles for article (PubMed ID: 26459826)
1. Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model.
Dowall SD; Bosworth A; Watson R; Bewley K; Taylor I; Rayner E; Hunter L; Pearson G; Easterbrook L; Pitman J; Hewson R; Carroll MW
J Gen Virol; 2015 Dec; 96(12):3484-3492. PubMed ID: 26459826
[TBL] [Abstract][Full Text] [Related]
2. Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig.
Lane TR; Massey C; Comer JE; Freiberg AN; Zhou H; Dyall J; Holbrook MR; Anantpadma M; Davey RA; Madrid PB; Ekins S
Antiviral Res; 2020 Sep; 181():104863. PubMed ID: 32682926
[TBL] [Abstract][Full Text] [Related]
3. Post-exposure treatment of Ebola virus disease in guinea pigs using EBOTAb, an ovine antibody-based therapeutic.
Dowall SD; Bosworth A; Rayner E; Taylor I; Landon J; Cameron I; Coxon R; Al Abdulla I; Graham VA; Hall G; Kobinger G; Hewson R; Carroll MW
Sci Rep; 2016 Jul; 6():30497. PubMed ID: 27465308
[TBL] [Abstract][Full Text] [Related]
4. Lack of protection against ebola virus from chloroquine in mice and hamsters.
Falzarano D; Safronetz D; Prescott J; Marzi A; Feldmann F; Feldmann H
Emerg Infect Dis; 2015 Jun; 21(6):1065-7. PubMed ID: 25988934
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus.
Cong Y; Dyall J; Hart BJ; DeWald LE; Johnson JC; Postnikova E; Zhou H; Gross R; Rojas O; Alexander I; Josleyn N; Zhang T; Michelotti J; Janosko K; Glass PJ; Flint M; McMullan LK; Spiropoulou CF; Mierzwa T; Guha R; Shinn P; Michael S; Klumpp-Thomas C; McKnight C; Thomas C; Eakin AE; O'Loughlin KG; Green CE; Catz P; Mirsalis JC; Honko AN; Olinger GG; Bennett RS; Holbrook MR; Hensley LE; Jahrling PB
PLoS One; 2016; 11(11):e0166318. PubMed ID: 27902714
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
[TBL] [Abstract][Full Text] [Related]
7. Minimal In Vivo Efficacy of Iminosugars in a Lethal Ebola Virus Guinea Pig Model.
Miller JL; Spiro SG; Dowall SD; Taylor I; Rule A; Alonzi DS; Sayce AC; Wright E; Bentley EM; Thom R; Hall G; Dwek RA; Hewson R; Zitzmann N
PLoS One; 2016; 11(11):e0167018. PubMed ID: 27880800
[TBL] [Abstract][Full Text] [Related]
8. The Drug Targets and Antiviral Molecules for Treatment of Ebola Virus Infection.
Wu W; Liu S
Curr Top Med Chem; 2017; 17(3):361-370. PubMed ID: 27572081
[TBL] [Abstract][Full Text] [Related]
9. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference.
Geisbert TW; Hensley LE; Kagan E; Yu EZ; Geisbert JB; Daddario-DiCaprio K; Fritz EA; Jahrling PB; McClintock K; Phelps JR; Lee AC; Judge A; Jeffs LB; MacLachlan I
J Infect Dis; 2006 Jun; 193(12):1650-7. PubMed ID: 16703508
[TBL] [Abstract][Full Text] [Related]
10. Antiviral effect of ranpirnase against Ebola virus.
Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
[TBL] [Abstract][Full Text] [Related]
11. Antiviral Screening of Multiple Compounds against Ebola Virus.
Dowall SD; Bewley K; Watson RJ; Vasan SS; Ghosh C; Konai MM; Gausdal G; Lorens JB; Long J; Barclay W; Garcia-Dorival I; Hiscox J; Bosworth A; Taylor I; Easterbrook L; Pitman J; Summers S; Chan-Pensley J; Funnell S; Vipond J; Charlton S; Haldar J; Hewson R; Carroll MW
Viruses; 2016 Oct; 8(11):. PubMed ID: 27801778
[TBL] [Abstract][Full Text] [Related]
12. Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
Selaković Ž; Tran JP; Kota KP; Lazić M; Retterer C; Besch R; Panchal RG; Soloveva V; Sean VA; Jay WB; Pavić A; Verbić T; Vasiljević B; Kuehl K; Duplantier AJ; Bavari S; Mudhasani R; Šolaja BA
Eur J Med Chem; 2019 Jan; 162():32-50. PubMed ID: 30408747
[TBL] [Abstract][Full Text] [Related]
13. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Ebola Glycoprotein-Specific Equine Polyclonal Antibody Product Against Lethal Ebola Virus Infection in Guinea Pigs.
Chan M; Holtsberg FW; Vu H; Howell KA; Leung A; Van der Hart E; Walz PH; Aman MJ; Kodihalli S; Kobasa D
J Infect Dis; 2018 Nov; 218(suppl_5):S603-S611. PubMed ID: 29955852
[TBL] [Abstract][Full Text] [Related]
15. Ebola virus (EBOV) infection: Therapeutic strategies.
De Clercq E
Biochem Pharmacol; 2015 Jan; 93(1):1-10. PubMed ID: 25481298
[TBL] [Abstract][Full Text] [Related]
16. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS
Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611
[TBL] [Abstract][Full Text] [Related]
19. Progression of Ebola Therapeutics During the 2014-2015 Outbreak.
Mendoza EJ; Qiu X; Kobinger GP
Trends Mol Med; 2016 Feb; 22(2):164-173. PubMed ID: 26774636
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Quinacrine against Ebola Virus Infection
Lane TR; Comer JE; Freiberg AN; Madrid PB; Ekins S
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31307979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
